Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.
USA is still the largest consumption region of Tekturna, occupied about 56% market share globally, with revenue 39.21 million USD in 2017. At the same time, Asia will see the considerable growth since Novartis DAC had successfully entered into an agreement with Orphan Pacific (Japan) and Lee’s Pharmaceutical Holdings Limited (China).
This report offers an overview of the market trends, drivers, and barriers with respect to the China Renin-Inhibitors market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Renin-Inhibitors market. Detailed analysis of key players, along with key growth strategies adopted by Renin-Inhibitors industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Noden Pharma
Novartis
By Type:
150mg/Tablet
300mg/Tablet
By End-User:
Age below 45
Age 45-55
Age 55-65
Age above 65
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Renin-Inhibitors Market
-
1.3 Market Segment by Type
-
1.3.1 China Renin-Inhibitors Market Size and Growth Rate of 150mg/Tablet from 2016 to 2027
-
1.3.2 China Renin-Inhibitors Market Size and Growth Rate of 300mg/Tablet from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Renin-Inhibitors Market Size and Growth Rate of Age below 45 from 2016 to 2027
-
1.4.2 China Renin-Inhibitors Market Size and Growth Rate of Age 45-55 from 2016 to 2027
-
1.4.3 China Renin-Inhibitors Market Size and Growth Rate of Age 55-65 from 2016 to 2027
-
1.4.4 China Renin-Inhibitors Market Size and Growth Rate of Age above 65 from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Renin-Inhibitors Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Renin-Inhibitors by Major Types
-
3.4.1 Market Size and Growth Rate of 150mg/Tablet
-
3.4.2 Market Size and Growth Rate of 300mg/Tablet
4 Segmentation of Renin-Inhibitors Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Renin-Inhibitors by Major End-Users
-
4.4.1 Market Size and Growth Rate of Renin-Inhibitors in Age below 45
-
4.4.2 Market Size and Growth Rate of Renin-Inhibitors in Age 45-55
-
4.4.3 Market Size and Growth Rate of Renin-Inhibitors in Age 55-65
-
4.4.4 Market Size and Growth Rate of Renin-Inhibitors in Age above 65
5 Market Analysis by Regions
-
5.1 China Renin-Inhibitors Production Analysis by Regions
-
5.2 China Renin-Inhibitors Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Renin-Inhibitors Landscape Analysis
-
6.1 North China Renin-Inhibitors Landscape Analysis by Major Types
-
6.2 North China Renin-Inhibitors Landscape Analysis by Major End-Users
7 Central China Renin-Inhibitors Landscape Analysis
-
7.1 Central China Renin-Inhibitors Landscape Analysis by Major Types
-
7.2 Central China Renin-Inhibitors Landscape Analysis by Major End-Users
8 South China Renin-Inhibitors Landscape Analysis
-
8.1 South China Renin-Inhibitors Landscape Analysis by Major Types
-
8.2 South China Renin-Inhibitors Landscape Analysis by Major End-Users
9 East China Renin-Inhibitors Landscape Analysis
-
9.1 East China Renin-Inhibitors Landscape Analysis by Major Types
-
9.2 East China Renin-Inhibitors Landscape Analysis by Major End-Users
10 Northeast China Renin-Inhibitors Landscape Analysis
-
10.1 Northeast China Renin-Inhibitors Landscape Analysis by Major Types
-
10.2 Northeast China Renin-Inhibitors Landscape Analysis by Major End-Users
11 Southwest China Renin-Inhibitors Landscape Analysis
-
11.1 Southwest China Renin-Inhibitors Landscape Analysis by Major Types
-
11.2 Southwest China Renin-Inhibitors Landscape Analysis by Major End-Users
12 Northwest China Renin-Inhibitors Landscape Analysis
-
12.1 Northwest China Renin-Inhibitors Landscape Analysis by Major Types
-
12.2 Northwest China Renin-Inhibitors Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Noden Pharma
-
13.1.1 Noden Pharma Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Novartis
-
13.2.1 Novartis Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Renin-Inhibitors Market Size and Growth Rate of 150mg/Tablet from 2016 to 2027
-
Figure China Renin-Inhibitors Market Size and Growth Rate of 300mg/Tablet from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Renin-Inhibitors Market Size and Growth Rate of Age below 45 from 2016 to 2027
-
Figure China Renin-Inhibitors Market Size and Growth Rate of Age 45-55 from 2016 to 2027
-
Figure China Renin-Inhibitors Market Size and Growth Rate of Age 55-65 from 2016 to 2027
-
Figure China Renin-Inhibitors Market Size and Growth Rate of Age above 65 from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Renin-Inhibitors Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Renin-Inhibitors
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Renin-Inhibitors by Different Types from 2016 to 2027
-
Table Consumption Share of Renin-Inhibitors by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 150mg/Tablet
-
Figure Market Size and Growth Rate of 300mg/Tablet
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Renin-Inhibitors by Different End-Users from 2016 to 2027
-
Table Consumption Share of Renin-Inhibitors by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Age below 45
-
Figure Market Size and Growth Rate of Age 45-55
-
Figure Market Size and Growth Rate of Age 55-65
-
Figure Market Size and Growth Rate of Age above 65
-
Table China Renin-Inhibitors Production by Regions
-
Table China Renin-Inhibitors Production Share by Regions
-
Figure China Renin-Inhibitors Production Share by Regions in 2016
-
Figure China Renin-Inhibitors Production Share by Regions in 2021
-
Figure China Renin-Inhibitors Production Share by Regions in 2027
-
Table China Renin-Inhibitors Consumption by Regions
-
Table China Renin-Inhibitors Consumption Share by Regions
-
Figure China Renin-Inhibitors Consumption Share by Regions in 2016
-
Figure China Renin-Inhibitors Consumption Share by Regions in 2021
-
Figure China Renin-Inhibitors Consumption Share by Regions in 2027
-
Table North China Renin-Inhibitors Consumption by Types from 2016 to 2027
-
Table North China Renin-Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure North China Renin-Inhibitors Consumption Share by Types in 2016
-
Figure North China Renin-Inhibitors Consumption Share by Types in 2021
-
Figure North China Renin-Inhibitors Consumption Share by Types in 2027
-
Table North China Renin-Inhibitors Consumption by End-Users from 2016 to 2027
-
Table North China Renin-Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure North China Renin-Inhibitors Consumption Share by End-Users in 2016
-
Figure North China Renin-Inhibitors Consumption Share by End-Users in 2021
-
Figure North China Renin-Inhibitors Consumption Share by End-Users in 2027
-
Table Central China Renin-Inhibitors Consumption by Types from 2016 to 2027
-
Table Central China Renin-Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Central China Renin-Inhibitors Consumption Share by Types in 2016
-
Figure Central China Renin-Inhibitors Consumption Share by Types in 2021
-
Figure Central China Renin-Inhibitors Consumption Share by Types in 2027
-
Table Central China Renin-Inhibitors Consumption by End-Users from 2016 to 2027
-
Table Central China Renin-Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Renin-Inhibitors Consumption Share by End-Users in 2016
-
Figure Central China Renin-Inhibitors Consumption Share by End-Users in 2021
-
Figure Central China Renin-Inhibitors Consumption Share by End-Users in 2027
-
Table South China Renin-Inhibitors Consumption by Types from 2016 to 2027
-
Table South China Renin-Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure South China Renin-Inhibitors Consumption Share by Types in 2016
-
Figure South China Renin-Inhibitors Consumption Share by Types in 2021
-
Figure South China Renin-Inhibitors Consumption Share by Types in 2027
-
Table South China Renin-Inhibitors Consumption by End-Users from 2016 to 2027
-
Table South China Renin-Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure South China Renin-Inhibitors Consumption Share by End-Users in 2016
-
Figure South China Renin-Inhibitors Consumption Share by End-Users in 2021
-
Figure South China Renin-Inhibitors Consumption Share by End-Users in 2027
-
Table East China Renin-Inhibitors Consumption by Types from 2016 to 2027
-
Table East China Renin-Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure East China Renin-Inhibitors Consumption Share by Types in 2016
-
Figure East China Renin-Inhibitors Consumption Share by Types in 2021
-
Figure East China Renin-Inhibitors Consumption Share by Types in 2027
-
Table East China Renin-Inhibitors Consumption by End-Users from 2016 to 2027
-
Table East China Renin-Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure East China Renin-Inhibitors Consumption Share by End-Users in 2016
-
Figure East China Renin-Inhibitors Consumption Share by End-Users in 2021
-
Figure East China Renin-Inhibitors Consumption Share by End-Users in 2027
-
Table Northeast China Renin-Inhibitors Consumption by Types from 2016 to 2027
-
Table Northeast China Renin-Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Renin-Inhibitors Consumption Share by Types in 2016
-
Figure Northeast China Renin-Inhibitors Consumption Share by Types in 2021
-
Figure Northeast China Renin-Inhibitors Consumption Share by Types in 2027
-
Table Northeast China Renin-Inhibitors Consumption by End-Users from 2016 to 2027
-
Table Northeast China Renin-Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Renin-Inhibitors Consumption Share by End-Users in 2016
-
Figure Northeast China Renin-Inhibitors Consumption Share by End-Users in 2021
-
Figure Northeast China Renin-Inhibitors Consumption Share by End-Users in 2027
-
Table Southwest China Renin-Inhibitors Consumption by Types from 2016 to 2027
-
Table Southwest China Renin-Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Renin-Inhibitors Consumption Share by Types in 2016
-
Figure Southwest China Renin-Inhibitors Consumption Share by Types in 2021
-
Figure Southwest China Renin-Inhibitors Consumption Share by Types in 2027
-
Table Southwest China Renin-Inhibitors Consumption by End-Users from 2016 to 2027
-
Table Southwest China Renin-Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Renin-Inhibitors Consumption Share by End-Users in 2016
-
Figure Southwest China Renin-Inhibitors Consumption Share by End-Users in 2021
-
Figure Southwest China Renin-Inhibitors Consumption Share by End-Users in 2027
-
Table Northwest China Renin-Inhibitors Consumption by Types from 2016 to 2027
-
Table Northwest China Renin-Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Renin-Inhibitors Consumption Share by Types in 2016
-
Figure Northwest China Renin-Inhibitors Consumption Share by Types in 2021
-
Figure Northwest China Renin-Inhibitors Consumption Share by Types in 2027
-
Table Northwest China Renin-Inhibitors Consumption by End-Users from 2016 to 2027
-
Table Northwest China Renin-Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Renin-Inhibitors Consumption Share by End-Users in 2016
-
Figure Northwest China Renin-Inhibitors Consumption Share by End-Users in 2021
-
Figure Northwest China Renin-Inhibitors Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Noden Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Noden Pharma
-
Figure Sales and Growth Rate Analysis of Noden Pharma
-
Figure Revenue and Market Share Analysis of Noden Pharma
-
Table Product and Service Introduction of Noden Pharma
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
